Gary A Dahl

This inventor holds 38 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 19 EPO patents, primarily in RNA Modifications. Top assignees: Epicentre Technologies Corporation, Cellscript, LLC, University of Pennsylvania. Active years: 1992-2026.

USPTO Granted Patents = 38 (Patent Applications = 9)

% Patents Active = 92.1

CIPO Patents = 1

EPO Patents = 19 (Patent Applications = 18)

Average Co-Inventor Count = 3.1

ph-index = 15

Forward Citations = 1,045(Granted Patents)

Location History:

Denver, CO (US) (1992)
Madison, WI (US) (1993 - 2024)

Company Filing History:

15 out of 28

Epicentre Technologies Corporation

University of Pennsylvania

5. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2026

Loading Chart...

Areas of Expertise:

RNA Preparations

Transposon Compositions

Immune Response Inhibition

Cell Reprogramming

5' Ligation Tagging

ssRNA Synthesis

Nucleic Acid Modification

Ribonuclease H

Eukaryotic Cells

Biochemical Effects

Directionally Truncated Polypeptides

Transcription Substrates

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12655395 - RNA PREPARATIONS COMPRISING PURIFIED MODIFIED RNA FOR REPROGRAMMING CELLS (2026-06-16),

2. 12371687 - Transposon end compositions and methods for modifying nucleic acids (2025-07-29),

3. 12059479 - Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect (2024-08-13),

4. 11739300 - RNA preparations comprising purified modified RNA for reprogramming cells (2023-08-29),

5. 11135314 - Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect (2021-10-05),

6. 11118175 - Transposon end compositions and methods for modifying nucleic acids (2021-09-14),

7. 11028370 - RNA preparations comprising purified modified RNA for reprogramming cells (2021-06-08),

8. 10793831 - Inhibition of innate immune response (2020-10-06),

9. 10201620 - Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect (2019-02-12),

10. 10184122 - Transposon end compositions and methods for modifying nucleic acids (2019-01-22),

11. 10006007 - RNA preparations comprising purified modified RNA for reprogramming cells (2018-06-26),

12. 9963735 - Selective 5' ligation tagging of RNA (2018-05-08),

13. 9862926 - Inhibition of innate immune response (2018-01-09),

14. 9371544 - Compositions and methods for reprogramming eukaryotic cells (2016-06-21),

15. 9371511 - RNA preparations comprising purified modified RNA for reprogramming cells (2016-06-21),

Title: The Story of Gary A. Dahl: Inventor Extraordinaire

Introduction: Gary A. Dahl, a renowned inventor hailing from Madison, WI, gained fame for his groundbreaking creation that took the world by storm.

Latest Patents: While Gary A. Dahl's most notable invention remains the Pet Rock, he continued to innovate in various fields, with his latest patents focusing on consumer products and novelty items.

Career Highlights: Throughout his career, Gary A. Dahl demonstrated a unique ability to identify gaps in the market and create products that captured the public's imagination. His entrepreneurial spirit and creative vision set him apart in the world of inventions.

Collaborations: Gary A. Dahl collaborated with a diverse range of professionals, from designers to marketers, to bring his inventions to life. His ability to work effectively in teams contributed to the success of his projects.

Conclusion: Gary A. Dahl's legacy as an inventor is marked by his ingenuity, creativity, and keen understanding of consumer preferences. His impact on the world of inventions continues to inspire aspiring innovators worldwide.